Monthly Archives: November 2009

A Lead Drug on the Way? All Eyes on FDA

By Brittany Agro | Published: November 4, 2009

For NeurogesX, a small biopharma company based in San Mateo, CA, time does not stand still. Every day preceding November 16 brings its flagship drug, Qutenza, one step closer to approval. Until then, the company has turned its energies to finalizing its US commercialization strategy. (NeurogesX previously entered into a commercialization agreement with Astellas Pharma [...]

Posted in Strategy | Tagged Biotechnology and Pharmaceuticals, business, Clinical trial, NeurogesX, Physician | Leave a comment

Pfizer Quietly Updates Company Logo

By George Koroneos | Published: November 4, 2009

A few weeks back, about the time Pfizer started swapping out Wyeth signs for Pfizer branding, I was tipped off that the age-old Pfizer logo had been modified from the horizontal blue oval to an offset design. Additionally, the company did tiny modifications on each letter, dropping the serif from the “P,” making the “F” less [...]

Posted in Strategy | Tagged Advertising, business, Design, Logo, Pepsi, Pfizer, Typeface, Wyeth | 7 Comments

AZ’s First Corporate Blog Falls Flat

By Andrew Sheivachman | Published: November 4, 2009

Currently, if patients or doctors look for specific drug information on AZ Health Connections, AstraZeneca’s new corporate communications blog, they won’t find any. And that’s exactly how AZ—along with pretty much every other pharma company engaged in the social media sphere—wants it. “The one area we’re trying not to engage is specific questions about disease state,” [...]

Posted in E-Media | Tagged AstraZeneca, Community, Company, Food and Drug Administration, Health care, social media, Virtual community, Washington DC | 3 Comments